Clinical trial • No longer enrolling • 14 March 2011
A Randomized, Double-Blind Study of the Safety and Efficacy of GSK1349572 Plus Abacavir/Lamivudine Fixed-Dose Combination Therapy Administered Once Daily Compared to Atripla Over 96 Weeks in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Clinical trial • Concluded • 24 March 2009
A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1
Tags: drug resistance, NNRTI
Clinical trial • Reported • 11 May 2007
A Randomised Open-Label Study Comparing the Safety and Efficacy of Three Different Combination Antiretroviral Regimens as Initial Therapy for HIV Infection
Tags: first-line therapy, starting treatments
Clinical trial • Enrolling • 27 June 2008
A Randomised, Double-blind, Placebo-controlled, Clinical Trial to Compare the Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) in Antiretroviral-naïve HIV-infected Individuals Over 96 Weeks
Tags: clinical trials
Clinical trial • Fully enrolled • 24 January 2012
Non-nucleoside Reverse Transcriptase Inhibitor Failure in a High HIV Caseload Australian Primary Care Practice
Clinical trial • Reported • 16 January 2012
An Investigational Vaccine in Reducing the Incidence of Anogenital Warts in Young Men
Tags: anal cancer, HPV
Clinical trial • Enrolling • 19 January 2012
A Multicenter, Randomized, Double Blind, Comparative Trial Of Maraviroc + Darunavir/Ritonavir Versus Emtricitabine/Tenofovir +Darunavir/Ritonavir For The Treatment Of Antiretroviral-Naïve HIV Infected Patients With Ccr5 Tropic HIV 1
Tags: maraviroc
Clinical trial • Enrolling • 25 March 2011
A Long Term Open-Label Extension Study of Lersivirine For The Treatment Of HIV-1 Infection
Clinical trial • Enrolling • 16 January 2012
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
This site complies with the HONcode standard for trustworthy health information: verify here. 